标题
Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma
作者
关键词
Bone marrow microenvironment, Epigenetics, Histone deacetylase, Histone methyltransferase
出版物
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 104, Issue 3, Pages 281-292
出版商
Springer Nature
发表日期
2016-07-13
DOI
10.1007/s12185-016-2048-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling
- (2016) Xing-Ding Zhang et al. CANCER CELL
- Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs
- (2016) Gerard L. Brien et al. CANCER CELL
- DNA methylation in normal and malignant hematopoiesis
- (2016) Hamza Celik et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses
- (2016) S J de Haart et al. Blood Cancer Journal
- Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
- (2015) Yuko Mishima et al. BRITISH JOURNAL OF HAEMATOLOGY
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Molecular pathogenesis of multiple myeloma
- (2015) Yusuke Furukawa et al. International Journal of Clinical Oncology
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma
- (2015) Jiro Kikuchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow
- (2015) T Matthes et al. LEUKEMIA
- KATs in cancer: functions and therapies
- (2015) A Farria et al. ONCOGENE
- Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
- (2015) S Ozaki et al. Blood Cancer Journal
- Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns
- (2015) Ingrid Cifola et al. Oncotarget
- CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
- (2015) Aldo M. Roccaro et al. Cell Reports
- Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
- (2015) Jahangir Abdi et al. Oncotarget
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
- (2014) Sridurga Mithraprabhu et al. Epigenetics
- Histone target selection within chromatin: an exemplary case of teamwork
- (2014) M.-E. Lalonde et al. GENES & DEVELOPMENT
- Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells
- (2014) Jiro Kikuchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Epigenetics of hematopoietic stem cell aging and disease
- (2014) Motohiko Oshima et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
- (2014) Goro Sashida et al. Nature Communications
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
- (2014) Relja Popovic et al. PLoS Genetics
- Romidepsin Overcomes Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma Cells
- (2013) Piyanuch Sripayap et al. ACTA HAEMATOLOGICA
- Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
- (2013) Teresa S. Hawley et al. AMERICAN JOURNAL OF HEMATOLOGY
- PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma
- (2013) P. G. Richardson et al. BLOOD
- Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
- (2013) B. Paiva et al. BLOOD
- A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma
- (2013) Maria T. Petrucci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
- (2013) Sebastian Bender et al. CANCER CELL
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- NSD2 Is Recruited through Its PHD Domain to Oncogenic Gene Loci to Drive Multiple Myeloma
- (2013) Z. Huang et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma
- (2013) Rogier M. Reijmers et al. FEBS Journal
- Multiple myeloma-initiating cells
- (2013) Naoki Hosen INTERNATIONAL JOURNAL OF HEMATOLOGY
- Molecular pathogenesis of multiple myeloma: basic and clinical updates
- (2013) Marta Chesi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The Novel Orally Active Proteasome Inhibitor K-7174 Exerts Anti-myeloma Activityin Vitroandin Vivoby Down-regulating the Expression of Class I Histone Deacetylases
- (2013) Jiro Kikuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction
- (2013) Hilaire C. Lam et al. JOURNAL OF CLINICAL INVESTIGATION
- Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
- (2013) Tomoya Muto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
- (2013) H. A. F. Stessman et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
- (2013) Rami Rahal et al. NATURE MEDICINE
- Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
- (2013) Christoph Plass et al. NATURE REVIEWS GENETICS
- Transcriptional regulation by Polycomb group proteins
- (2013) Luciano Di Croce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Determinants of nucleosome positioning
- (2013) Kevin Struhl et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells
- (2013) Miho Nara et al. PLoS One
- Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells
- (2013) D Chiron et al. Blood Cancer Journal
- Targeting the BRAF V600E Mutation in Multiple Myeloma
- (2013) M. Andrulis et al. Cancer Discovery
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
- (2012) B. A. Walker et al. BLOOD
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- Enhancers: emerging roles in cell fate specification
- (2012) Chin-Tong Ong et al. EMBO REPORTS
- Discovering common combinatorial histone modification patterns in the human genome
- (2012) Changgui Linghu et al. GENE
- A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
- (2012) C. Simon et al. GENES & DEVELOPMENT
- CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
- (2012) N Hosen et al. LEUKEMIA
- Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF- B Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop
- (2012) P. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- Integrin 7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
- (2011) P. Neri et al. BLOOD
- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
- (2011) F. Gay et al. BLOOD
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The diverse functions of Dot1 and H3K79 methylation
- (2011) A. T. Nguyen et al. GENES & DEVELOPMENT
- Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
- (2011) Masahiro Abe INTERNATIONAL JOURNAL OF HEMATOLOGY
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites
- (2011) Huadong Pei et al. NATURE
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Classical and/or alternative NF- B pathway activation in multiple myeloma
- (2010) Y. N. Demchenko et al. BLOOD
- Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
- (2010) J. Kikuchi et al. BLOOD
- The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
- (2010) E. Martinez-Garcia et al. BLOOD
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
- (2010) Viviana Moresi et al. CELL
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Discovery and characterization of chromatin states for systematic annotation of the human genome
- (2010) Jason Ernst et al. NATURE BIOTECHNOLOGY
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- 1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
- (2009) K. H. Shain et al. CANCER RESEARCH
- A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma
- (2008) J. Kirshner et al. BLOOD
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
- (2008) S. Sander et al. BLOOD
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
- (2008) W. Matsui et al. CANCER RESEARCH
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells
- (2008) J. L.R. Brito et al. HAEMATOLOGICA
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
- (2007) J. Marango et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More